newsfilter
← Latest News
GlobeNewswire·

Harvard Bioscience Announces Third Quarter 2025 Financial Results

Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by OperationsCompany Expects to Refinance or Repay the Debt in the Fourth QuarterFourth Quarter 2025 Guidance Reflects Increased